Oxford Drug Design awarded share of £3m Cystic Fibrosis Collaborative Drug Discovery Programme
The cross-sector initiative provides funding and support to accelerate new treatments for lung infections in Cystic Fibrosis September 26th 2024, United Kingdom: […]